Abstract
Makorin-2 (Mkrn2) is an evolutionarily conserved gene whose biological functions are not fully known. Although recent studies have shed insights on the potential causes of male infertility, its underlining mechanisms still remain to be elucidated. We developed a Mrkn2 knockout mice model to study this gene and found that deletion of Mkrn2 in mice led to male infertility. Interestingly, the expression level of signal transducer and activator of the transcription (STAT)1 was significantly decreased in MKRN2 knockout testis and MEF cells. Co-IP assay showed an interaction between MKRN2 and STAT1. Moreover, our results further indicated that MKRN2 regulated the expression level of SIX4 and tenascin C (TNC) via the EBF transcription factor 2 (EBF2) in mice. The results of our study will provide insights into a new mechanism of male infertility.
Introduction
Makorin-2 (MKRN2; HSPC070) belongs to the MKRN gene family with the ribonucleoproteins characterized by a variety of zinc-finger motifs, which contains four C3H zinc fingers and a C3HC4 really interesting new gene (RING) zinc finger domain (1, 2). MKRN2 was first identified in human CD34+stem/progenitor cells, as well as in some leukemic cell lines (1, 3, 4). Previous studies reported that mkrn2 in Xenopus laevis acted upstream of glycogen synthase kinase-3b in the phosphatidylinositol 3-kinase/Akt pathway. The third C3H zinc finger and the RING motif are required for the antineurogenesis activity (5, 6). Recent studies also investigated the role of MKRN2 in tumorigenesis, such as lung cancer and melanoma (7, 8). Though MKRN2 is a highly conserved gene, however, its function remains largely unknown.
The signal transducer and activator of the transcription (STAT) protein family mediate the transcription of several genes, such as cytokine-inducible genes and growth factors (9–12). So far, seven STAT proteins have been identified: STAT1–6 and STAT5b (13, 14). When the receptor bounds to STATs, a conserved tyrosine residue in the C-terminal domain will be phosphorylated by the Janus kinase (JAK), then two STATs assemble through reciprocal phosphotyrosine/SH2 domain interactions leading to dimerization. Once dimerized, STATs are translocated into the nucleus and regulate the transcription of several different genes. Truchet et al. reported that JAK/STAT pathway is functional during early embryonic development, and STAT1 is present in mouse oocytes and in preimplantation embryos (15). STAT1 was reported to be phosphorylated in response to capacitation and the acrosomal reaction (16). Moreover, human samples with varicocele conveyed a significant negative correlation between the phosphorylated levels of STAT1 and sperm head morphological defects (17). Moreover, The Six4 genes belong to the mammalian homolog of the Drosophila sine oculis homeobox (Six) family, and studies have reported that SIX4 is required for genital primordium formation and testicular differentiation of male gonads (18). SIX4 and tenascin C (TNC) have been reported to be functioning in a productive system. Thus, we wonder how to evaluate the regulatory mechanism between MKRN2 and STAT1/SIX4/TNC to figure out the novel mechanism of MKRN2 in male infertility.
In this study, we plan to address: (a) the role of MKRN2 in male infertility; (b) whether MKRN2 regulates the expression level of STAT1; and (c) how MKRN2 induces the expression levels of SIX4 and TNC by the transcription factor EBF transcription factor 2 (EBF2). The results of our study will provide insights into a new mechanism of MKRN2 in regulating male infertility.
Materials and methods
Generation of Mkrn2-knockout mice
To generate Mkrn2-heterozygous and Mkrn2-knockout mice, Mkrn2-floxed mice have been crossed with transgenic EIIa-cre mice with a C57BL/6 J background as we previously described (19) to obtain mosaic mice with the Mkrn2+/flox(−)·EIIa-cre genotype. The resulting mice were crossed with C57BL/6 J to obtain Mkrn2 heterozygotes. Mkrn2 knockout mice were generated by sibmating Mkrn2 heterozygotes. Genomic DNAs isolated from the tails were genotyped with indicated primers by PCR as described (19). All the animals were housed in specific pathogen-free conditions, and all the experiments were approved by the Committee of Laboratory Animal Experimentation of Zhengzhou University.
Cell culture
Mkrn2-WT and Mkrn2-KO primary mouse embryonic fibroblasts (MEFs) were derived from 13.5-day embryos and cultured as described (19), and 293T cells were cultured in the DMEM medium supplemented with 10% FBS, penicillin (100 U/ml), and streptomycin (100 μg/ml), and were maintained at 37°C.
H&E staining
The H&E staining procedure used here is as follows: (a) Deparaffinize all sections in xylene two times for 10 min each. (b) Gradually rehydrate sections with graded alcohol: wash in absolute alcohol two times for 5 min each, then 95% alcohol for 2 min, and 70% alcohol for 2 min. (c) Briefly wash in distilled water. (d) Stain in Harris hematoxylin solution for 8 min, then wash for 5 min under running water. (e) Differentiate in 1% acid alcohol for 30 s, then wash under running water for 1 min. (f) Blue in 0.2% ammonia water for 30 s, then wash under running water for 5 min. (g) Rinse in 95% alcohol at 10 dips. (h) Counterstain in an eosin–phloxine solution for 1 min. (i) Dehydrate with 95% alcohol and wash with absolute alcohol two times at 5 min each. (j) Clear in xylene two times at 5 min each. (k) Lastly, mount with a xylene-based mounting medium.
Western blot analysis
Cells were harvested, washed with cold PBS twice, and then suspended in 200 μl of cold cell lysed buffer with protease inhibitor. Tissues were homogenized and suspended in 500 μl of cold cell lysed buffer with protease inhibitor. All of the lysates were incubated on ice for 30 min and centrifuged for 10 min at 4°C; the supernatants were collected, and the protein concentration was quantified using the Bradford method (20). The cell lysates were resolved by SDS-PAGE and transferred onto polyvinylidene fluoride (PVDF) membranes. After being incubated in the blocking buffer (5% BSA in TBST) for 2 h at room temperature, the membranes were incubated with primer antibodies overnight at 4°C, washed three times with TBST, and incubated with HRP-conjugated secondary antibodies for 1 h at room temperature, then washed three times more with TBST. The protein–antibody complex was detected by a chemiluminescence detection system via an ECL chemiluminescence detection kit.
Quantitative real-time PCR
Quantitative real-time RT-PCR was used to determine the gene expression levels. RNAs were extracted using a Trizol reagent, reverse transcribed using SYBR Premix Dimer Eraser, and real-time PCR was performed using QuautStudio-5 Real-Time Thermal Cycler (ABI, Los Angeles, CA, USA). The following primer sequences were used for Q-PCR: Six4 forward primer: 5′-CTCCTGTCTCAGTAGCAGCTTC-3′; reverse primer: 5′-GGAACGGTGTATACCACTGCAC-3′; Ebf2 forward primer: 5′-GAGCAAGAAGGCTTGACCCATC-3′; reverse primer: 5′-CCAAACACAACCTGGAGACCATC-3′; Tnc forward primer: 5′-GAGACCTGACACGGAGTATGAG-3′; reverse primer: 5′-CTCCAAGGTGATGCTGTTGTCTG-3′; and GAPDH forward primer: 5′-ATGGGTGTGAACCATGAGAAGTATG-3′; reverse primer: 5′-GGTGCAGGAGGCATTGCT-3′. The gene expression levels were normalized to the value of GAPDH, and fold changes were calculated by relative quantification (2−ΔΔCt).
Co-immunoprecipitation
HEK293T cells were cultured in a 10-cm plate and transfected with the indicated plasmids for 48–72 h. Cells were then collected and lysed in immunoprecipitation (IP) buffer (1 M Tris, 0.5 M EDTA, 5 M NaCl, 100% glycerol, 100% Np40) and treated with antibodies at 4°C overnight. The lysis was then incubated with agarose beads (Roche, Indianapolis, IN, USA) for 4–6 h at 4°C. IP samples were separated by 8%–10% SDS-PAGE gels, and protein bands were detected by the chemiluminescent substrate.
Protein quantification and differently expressed protein analysis
Total proteins were extracted from Mkrn2-WT and Mkrn2-KO MEFs, with four biological repetitions in each group. The proteins of different samples were respectively subjected to trypsin enzymatic hydrolysis, and peptide fractionation as described (21). The samples were further analyzed on a Thermo HFX MS (Thermo Fisher Scientific, Waltham, MA, USA) interfaced with an EASY-nLC1200 LC system (Thermo Fisher Scientific). Raw files were searched against the mouse refseq protein database (27,414 proteins, version 04/07/2013) with Proteome Discoverer (Thermo Fisher Scientific, version 1.4). The levels of proteins were estimated with a label-free, intensity-based absolute quantification (iBAQ) approach (22). The iBAQ of each protein was normalized by dividing the sum of all identified proteins. We replaced the extremely small values with 10−8. The matrix file integrated with all samples was subjected to different protein expression between Mkrn2-WT MEFs and Mkrn2-KO MEFs by using the limma package in R 3.6.1 software (23). Different proteins were filtered by |Log2(Fold Change)|>1 and p-value < 0.05. Heatmap shows 977 differently expressed proteins.
Pathway enrichment analysis
The pathway enrichment analysis of differently expressed proteins was performed with the Reactome database, using the ReactomePA package in R software. Default parameters (OrgDb, org.Mm.eg.db; p-value cutoff, 0.05; q-value cutoff, 0.2; p-value adjust method, BH; readable, T) were set for pathway enrichment analysis. Enriched pathways with FDR < 0.2 were considered statistically significant.
Differently expressed gene analysis
The matrix data from GEO (GSE6872) is an expression profiling array, and the analysis of differently expressed genes was performed by using the limma package in R software (24). The threshold for differently expressed genes is |Log2(Fold Change)| > 1 and p-value < 0.05. The volcano plot shows analysis results including upregulated genes (red), downregulated genes (blue), and nonsignificant genes (black).
Statistical analysis
All results have been obtained from at least three independent experiments, and data were analyzed via GraphPad Prism 8 software. The statistical evaluation for data analysis was determined by a t-test. The differences were considered to be statistically significant at p < 0.05.
Results
MKRN2 is related to male spermatogenesis
In order to investigate the effects of MKRN2 on male spermatogenesis, we detected the macroscopic appearance of the testis of Mkrn2 knockout and wild-type (WT) mice via HE staining. We selected the testis at phase VIII of testicular development and epididymis, and the results showed that compared to the wild-type group, there were no sperm in the testis of Mkrn2 knockout mice (Figures 1A, B). In our previous study, we showed that Mkrn2 knockout induced spermiation failure, but we also found that a few Mkrn2 knockout mice had another new phenotype in which there is no sperm generated. We then analyzed the MKRN2 expression level of four normal spermatogenesis individuals (normal) and 27 nonobstructive azoospermia samples (patients) from the GEO dataset GSE45885. The results showed that the expression level of MKRN2 was significantly lower than the normal individuals (Figure 1C). These results suggested that MKRN2 played a key role in testicular development and male spermatogenesis.
Figure 1
MKRN2 expression levels are highly correlated with the receptor tyrosine kinase signaling pathway
To investigate the role of MKRN2 in testicular development and male spermatogenesis further, we performed a proteomics analysis of Mkrn2-WT MEFs and Mkrn2-KO MEFs (Figure 2A), as well as an analysis of differential expression genes (DEGs) in normospermic and teratozoospermic groups from the GEO dataset GSE6872 (Figure 2B). The signaling pathways represented among overlapping genes and ranked according to the number of enriched genes were screened for overlapping genes between differentially expressed proteins from proteomics and DEGs from GSE6872. The results showed that the primary signaling pathway (Figures 2C, D) was receptor tyrosine kinase signaling. We performed a transcription factor assay to compare the different transcription factors between Mkrn2-WT and Mkrn2-KO MEFS, and the overlapping genes of the transcription factor array and genes of the receptor tyrosine kinase signaling pathway were analyzed. STAT1 was the only gene that overlapped (Figure 2E). We then analyzed the expression levels of STAT family members in Mkrn2-WT MEFs and Mkrn2-KO MEFs according to the transcription factor array results, and STAT1 was the most downregulated gene in the Mkrn2-KO MEFs (Figure 2F). All of these results indicated that MKRN2-regulated STAT1 is involved in the process of male infertility.
Figure 2
MKRN2 regulates the expression level of STAT1
To further investigate the regulatory effect of MKRN2 on STAT1, we measured the protein and mRNA expression levels of MKRN2 and STAT1 in Mkrn2-WT MEFs and Mkrn2-KO MEFs, and the results showed that the expression level of STAT1 was significantly downregulated in Mkrn2-KO MEFs (Figure 3A). We then overexpressed MKRN2 in the 293T cells and measured the protein and mRNA expression levels of STAT1. The results showed that the expression level of STAT1 was significantly upregulated in MKRN2 overexpression cells (Figure 3B). We further found that MKRN2 could interact with STAT1 using a co-immunoprecipitation assay (Figure 3C). All of these results indicated that MKRN2 could interact with STAT1 and regulate its expression level.
Figure 3
MKRN2 mediates male teratozoospermia by regulating the expression level of STAT1
To verify the role of MKRN2 in the male teratozoospermia, we analyzed the expression levels of MKRN2 and STAT1 in 13 normally fertile male patients and eight infertile individuals with a severe and consistent heterogeneous teratozoospermia based on the GEO dataset GSE6872. The results showed that the expression levels of MKRN2 and STAT1 were both significantly downregulated in the infertile patients (Figure 4A). We then detected the protein and mRNA expression levels of MKRN2 and STAT1 in the testis of Mkrn2 knockout and wild-type (WT) mice and found that the expression levels of MKRN2 and STAT1were both significantly downregulated in the testis tissues of Mkrn2 knockout mice (Figures 4B–D). These results indicated that MKRN2 mediated male teratozoospermia by regulating the expression level of STAT1.
Figure 4
MKRN2 knockout results in the reproductive pathway disorder
To further investigate the effects of Mkrn2 on other reproductive pathways, we obtained a dataset of all genes related to reproduction from the Mouse Genome Informatics (MGI) website (http://www.informatics.jax.org/), overlapped the differentially expressed proteins of Mkrn2-WT MEFs and Mkrn2-KO MEFs and the reproduction-related genes, and then obtained 68 overlapped genes (Figure 5A). We then looked into the overlap of differentially expressed proteins from proteomics, genes from reproduction pathway, and genes from related molecular function sets of male infertility. There were nine overlapping genes with male gonad development (Figure 5B), 18 with spermatogenesis (Figure 5C), 18 with male gamete generation (Figure 5D), and two with prostate gland development (Figure 5E). All of the above findings suggested that MKRN2 knockout cause a disruption in the reproductive pathway.
Figure 5
MKRN2 regulates the expression of SIX4 and TNC
To further investigate the molecular mechanism of the above reproductive-related genes in male teratozoospermia, we verified expression levels of SIX4 and TNC in Mkrn2-WT MEFs and Mkrn2-KO MEFs using the proteomics data. The results showed that the expression levels of SIX4 and TNC were significantly downregulated in the Mkrn2-KO MEFs (Figure 6A). We then overlapped the putative upstream transcription factors of SIX4 or TNC according to the Jaspar website and differentially expressed proteins from proteomics and found only one transcription factor, EBF2 (Figure 6B). The mRNA expression levels of SIX4, TNC, and EBF2 were detected in Mkrn2-WT MEFs and Mkrn2-KO MEFs, and we found that the expression levels of SIX4, TNC, and transcription factor EBF2 were significantly downregulated in Mkrn2-KO MEFs (Figure 6C). We also used Western blot to examine the testis tissues of Mkrn2-WT and Mkrn2-KO mice, and the results showed that the protein expression levels of EBF2, SIX4, and TNC were decreased in Mkrn2-KO mice (Figure 6D). These findings indicated that MKRN2 regulated the expression level of SIX4 and TNC in Mkrn2 knockout mice via the transcription factor EBF2.
Figure 6
Discussion
The MKRN2 gene is a member of the makorin gene family, which also includes MKRN1, MKRN2, and MKRN3. MKRN2 has been found to be highly conserved throughout evolution, and its ancestral origin can be traced back to 450 million years ago, possibly as a result of MKRN1 gene duplication (1). We have illustrated the functional role of Mkrn2 in Xenopus embryos to negatively regulate neurogenesis through PI3K/Akt signaling. However, the potential functions and molecular mechanisms of MKRN2 in mammals remain to be studied. This Mkrn2 knockout mouse model and an independent GEO dataset of human sperm samples were used in this study to demonstrate the important role of MKRN2 in male fertility.
Previous studies have reported that MKRN2 inhibits the cell migration and invasion of non-small cell lung cancer by downregulating the PI3K/Akt pathway and is associated with lymph node metastasis, TNM stage, and cell differentiation (7). MKRN2 also acts as an E3 ligase for the NF-κB p65 subunit and has a negative regulatory effect on the inflammatory response (25).
Few reports have focused on the regulation of MKRN2 in male infertility. Our previous results demonstrated that Mkrn2 deletion in somatic Sertoli cells disrupted ectoplasmic specialization (ES), resulting in abnormalities in sperm heads and spermiation failure, both of which are essential to spermiogenesis. Moreover, Mkrn2 is crucial for protecting germ cells from apoptosis in spermatogenesis and male fertility via the p53/PERP signaling pathway. In this study, we focus on another phenotype of Mkrn2 knockout mice: no sperm generated, which may indicate the essential role of MKRN2 in male fertility. In this study, we found a new regulatory mechanism between MKRN2 and STAT1/SIX4/TNC, which is a novel mechanism of MKRN2 in regulating male infertility.
Recent studies have shown that the testis shares many similarities with cancerous tissues, including cell division, immigration, and immortalization. Cancer–testis (CT) antigens are usually expressed only in testis tissues, with the exception of early-developing embryos. In addition, CT antigens are expressed in various tumor types (26). The CT genes, OIP5, TAF7L, and AURKC have been identified as biomarkers for breast cancer and may be promising and potent candidates for therapeutic cancer vaccines (27, 28). MKRN2 may function as a cancer–testis antigen, with dual roles in tumorigenesis and spermiogenesis that need to be further investigated.
In this study, MKRN2 could interact with STAT1 and regulate its expression level, as well as the expression levels of SIX4 and TNC via the transcription factor EBF2. These results suggested that MKRN2 played a key role in testicular development and male spermatogenesis.
Statements
Data availability statement
The original contributions presented in the study are included in the article/supplementary material. Further inquiries can be directed to the corresponding authors.
Ethics statement
The animal study was reviewed and approved by Committee of Laboratory Animal Experimentation of Zhengzhou University.
Author contributions
J-GQ and B-HJ designed experiments and prepared the manuscript. LW, Y-LY, and K-KW performed experiments and analyzed the data. Y-XX, Y-CQ, and F-MZ analyzed clinical samples and provided technical support. B-HJ provided advice. All authors contributed to the article and approved the submitted version.
Funding
This work was supported in part by the National Natural Science Foundation of China (No. 81903174).
Conflict of interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
References
1
GrayTAAzamaKWhitmoreKMinAAbeSNichollsRD. Phylogenetic conservation of the makorin-2 gene, encoding a multiple zinc-finger protein, antisense to the RAF1 proto-oncogene. Genomics (2001) 77(3):119–26. doi: 10.1006/geno.2001.6627
2
GrayTAHernandezLCareyAHSchaldachMASmithwickMJRusKet al. The ancient source of a distinct gene family encoding proteins featuring RING and C(3)H zinc-finger motifs with abundant expression in developing brain and nervous system. Genomics (2000) 66(1):76–86. doi: 10.1006/geno.2000.6199
3
MaoMFuGWuJSZhangQHZhouJKanLXet al. Identification of genes expressed in human CD34(+) hematopoietic stem/progenitor cells by expressed sequence tags and efficient full-length cDNA cloning. Proc Natl Acad Sci U S A (1998) 95(14):8175–80. doi: 10.1073/pnas.95.14.8175
4
ZhangQHYeMWuXYRenSXZhaoMZhaoCJet al. Cloning and functional analysis of cDNAs with open reading frames for 300 previously undefined genes expressed in CD34+ hematopoietic stem/progenitor cells. Genome Res (2000) 10(10):1546–60. doi: 10.1101/gr.140200
5
CheungWKYangPHHuangQHChenZChenSJLinMCet al. Identification of protein domains required for makorin-2-mediated neurogenesis inhibition in xenopus embryos. Biochem Biophys Res Commun (2010) 394(1):18–23. doi: 10.1016/j.bbrc.2010.02.041
6
YangPHCheungWKPengYHeMLWuGQXieDet al. Makorin-2 is a neurogenesis inhibitor downstream of phosphatidylinositol 3-kinase/Akt (PI3K/Akt) signal. J Biol Chem (2008) 283(13):8486–95. doi: 10.1074/jbc.M704768200
7
JiangJXuYRenHWuduMWangQSongXet al. MKRN2 inhibits migration and invasion of non-small-cell lung cancer by negatively regulating the PI3K/Akt pathway. J Exp Clin Cancer Res (2018) 37(1):189. doi: 10.1186/s13046-018-0855-7
8
ZhangYCuiNZhengG. Ubiquitination of P53 by E3 ligase MKRN2 promotes melanoma cell proliferation. Oncol Lett (2020) 19(3):1975–84. doi: 10.3892/ol.2020.11261
9
DarnellJEJr.KerrIMStarkGR. Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science (1994) 264(5164):1415–21. doi: 10.1126/science.8197455
10
IhleJN. The stat family in cytokine signaling. Curr Opin Cell Biol (2001) 13(2):211–7. doi: 10.1016/s0955-0674(00)00199-x
11
LeamanDWLeungSLiXStarkGR. Regulation of STAT-dependent pathways by growth factors and cytokines. FASEB J (1996) 10(14):1578–88.
12
SchindlerC. Cytokines and JAK-STAT signaling. Exp Cell Res (1999) 253(1):7–14. doi: 10.1006/excr.1999.4670
13
DarnellJEJr. STATs and gene regulation. Science (1997) 277(5332):1630–5. doi: 10.1126/science.277.5332.1630
14
O'SheaJJGadinaMSchreiberRD. Cytokine signaling in 2002: new surprises in the Jak/Stat pathway. Cell (2002) 109 Suppl:S121–31. doi: 10.1016/s0092-8674(02)00701-8
15
TruchetSChebroutMDjediatCWietzerbinJDebeyP. Presence of permanently activated signal transducers and activators of transcription in nuclear interchromatin granules of unstimulated mouse oocytes and preimplantation embryos. Biol Reprod (2004) 71(4):1330–9. doi: 10.1095/biolreprod.104.029405
16
BastianYZepeda-BastidaAUribeSMujicaA. In spermatozoa, Stat1 is activated during capacitation and the acrosomal reaction. Reproduction (2007) 134(3):425–33. doi: 10.1530/REP-06-0264
17
SilvaJVFreitasMJCorreiaBRKorrodi-GregorioLPatricioAPelechSet al. Profiling signaling proteins in human spermatozoa: biomarker identification for sperm quality evaluation. Fertil Steril (2015) 104(4):845–56.e8. doi: 10.1016/j.fertnstert.2015.06.039
18
FujimotoYTanakaSSYamaguchiYLKobayashiHKurokiSTachibanaMet al. Homeoproteins Six1 and Six4 regulate male sex determination and mouse gonadal development. Dev Cell (2013) 26(4):416–30. doi: 10.1016/j.devcel.2013.06.018
19
QianXWangLZhengBShiZMGeXJiangCFet al. Deficiency of Mkrn2 causes abnormal spermiogenesis and spermiation, and impairs male fertility. Sci Rep (2016) 6:39318. doi: 10.1038/srep39318
20
BradfordMM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem (1976) 72:248–54. doi: 10.1006/abio.1976.9999
21
ZhouQLiuMXiaXGongTFengJLiuWet al. A mouse tissue transcription factor atlas. Nat Commun (2017) 8:15089. doi: 10.1038/ncomms15089
22
SchwanhausserBBusseDLiNDittmarGSchuchhardtJWolfJet al. Global quantification of mammalian gene expression control. Nature (2011) 473(7347):337–42. doi: 10.1038/nature10098
23
van OoijenMPJongVLEijkemansMJCHeckAJRAndewegACBinaiNAet al. Identification of differentially expressed peptides in high-throughput proteomics data. Brief Bioinform (2018) 19(5):971–81. doi: 10.1093/bib/bbx031
24
RitchieMEPhipsonBWuDHuYLawCWShiWet al. Limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res (2015) 43(7):e47. doi: 10.1093/nar/gkv007
25
ShinCItoYIchikawaSTokunagaMSakata-SogawaKTanakaT. MKRN2 is a novel ubiquitin E3 ligase for the p65 subunit of NF-kappaB and negatively regulates inflammatory responses. Sci Rep (2017) 7:46097. doi: 10.1038/srep46097
26
WhitehurstAW. Cause and consequence of cancer/testis antigen activation in cancer. Annu Rev Pharmacol Toxicol (2014) 54:251–72. doi: 10.1146/annurev-pharmtox-011112-140326
27
MobasheriMBShirkoohiRModarressiMH. Cancer/Testis OIP5 and TAF7L genes are up-regulated in breast cancer. Asian Pac J Cancer Prev (2015) 16(11):4623–8. doi: 10.7314/apjcp.2015.16.11.4623
28
MobasheriMBShirkoohiRZendehdelKJahanzadITalebiSAfsharpadMet al. Transcriptome analysis of the cancer/testis genes, DAZ1, AURKC, and TEX101, in breast tumors and six breast cancer cell lines. Tumour Biol (2015) 36(10):8201–6. doi: 10.1007/s13277-015-3546-4
Summary
Keywords
MKRN2, STAT1, SIX4, TNC, male infertility
Citation
Wang L, Yong Y-L, Wang K-K, Xie Y-X, Qian Y-C, Zhou F-M, Qiu J-G and Jiang B-H (2023) MKRN2 knockout causes male infertility through decreasing STAT1, SIX4, and TNC expression. Front. Endocrinol. 14:1138096. doi: 10.3389/fendo.2023.1138096
Received
05 January 2023
Accepted
24 February 2023
Published
10 March 2023
Volume
14 - 2023
Edited by
Shun Bai, University of Science and Technology of China, China
Reviewed by
Kaiqiang Fu, Qingdao Agricultural University, China; Haoyu Zheng, Huai’an First People’s Hospital, China
Updates
Copyright
© 2023 Wang, Yong, Wang, Xie, Qian, Zhou, Qiu and Jiang.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Bing-Hua Jiang, binghjiang@zzu.edu.cn; Jian-Ge Qiu, jiangeqiu@zzu.edu.cn
†These authors have contributed equally to this work
This article was submitted to Reproduction, a section of the journal Frontiers in Endocrinology
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.